Generation Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Sales Results.
Generation Bio Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Sales Results.
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersDelcath Systems (NASDAQ:DCTH) stock rose 33.2% to $7.19 during Tuesday's regular session. The company's market cap stands at $199.8 million. As per the news, the Q1 earnings report came out tod
Analysts Offer Insights on Healthcare Companies: Allogene Therapeutics (ALLO) and Generation Bio (GBIO)
Express News | Wedbush Reiterates Outperform on Generation Bio, Maintains $5 Price Target
Wedbush Remains a Buy on Generation Bio (GBIO)
Analysts Offer Insights on Healthcare Companies: Wuxi Biologics (Cayman) (OtherWXIBF) and Generation Bio (GBIO)
Express News | Generation Bio Q1 2024 Adj EPS $(1.12) Misses $(0.41) Estimate, Sales $4.059M Beat $1.920M Estimate
Generation Bio | 10-Q: Quarterly report
Express News | Generation Bio Co: Cash Balance of $233.9 Mln Still Expected to Fund Operations Into 2H 2027
Express News | Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
Express News | Generation Bio Q1 Operating Income USD -77.634 Million
Express News | Generation Bio Q1 Operating Expenses USD 81.693 Million
Express News | Generation Bio Q1 Basic EPS USD -1.12
Generation Bio 1Q Loss/Shr $1.12 >GBIO
Generation Bio 1Q Loss/Shr $1.12 >GBIO
Press Release: Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
Generation Bio Announces the Presentation of Preclinical Data on IqDNA and CtLNP Platforms at the ASGCT 27th Annual Meeting
Data presented show immune-quiet DNA (iqDNA) is a partially single-stranded DNA cargo that maintains expression while evading innate immune sensorsRapid enzymatic synthesis continues to improve iqDNA
Express News | Bioceres Crop Solutions Corp - Announces Brazil's Approval of New Generation Bio-Insecticide
Express News | Generation Bio Reports Acceptance Of Five Abstracts And An Invited Oral Presentation At ASGCT 27th Annual Meeting
Express News | Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (Asgct) 27TH Annual Meeting
Generation Bio Price Target Maintained With a $10.00/Share by Needham
Generation Bio Price Target Maintained With a $10.00/Share by Needham
No Data